Tenaya Therapeutics Inc (NASDAQ: TNYA) on Tuesday, soared 2.91% from the previous trading day, before settling in for the closing price of $1.72. Within the past 52 weeks, TNYA’s price has moved between $0.36 and $4.01.
During the last 5-year period, the sales drop of Healthcare Sector giant was -15.48%. The company achieved an average annual earnings per share of 47.83%. With a float of $138.17 million, this company’s outstanding shares have now reached $162.98 million.
Tenaya Therapeutics Inc (TNYA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tenaya Therapeutics Inc is 15.22%, while institutional ownership is 18.01%. The most recent insider transaction that took place on Aug 18 ’25, was worth 3,711. In this transaction SVP, Finance of this company sold 2,962 shares at a rate of $1.25, taking the stock ownership to the 95,338 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Chief Medical Officer sold 5,053 for $1.25, making the entire transaction worth $6,331. This insider now owns 172,803 shares in total.
Tenaya Therapeutics Inc (TNYA) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.3 earnings per share (EPS) for the period topping the consensus outlook (set at -0.37) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.83% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Tenaya Therapeutics Inc (TNYA) is currently performing well based on its current performance indicators. A quick ratio of 6.00 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Looking closely at Tenaya Therapeutics Inc (NASDAQ: TNYA), its last 5-days average volume was 3.47 million, which is a jump from its year-to-date volume of 3.03 million. As of the previous 9 days, the stock’s Stochastic %D was 84.79%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 95.27%, which indicates a significant increase from 88.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1236 in the past 14 days, which was higher than the 0.0841 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1769, while its 200-day Moving Average is $0.8858. However, in the short run, Tenaya Therapeutics Inc’s stock first resistance to watch stands at $1.8467. Second resistance stands at $1.9233. The third major resistance level sits at $2.0067. If the price goes on to break the first support level at $1.6867, it is likely to go to the next support level at $1.6033. Now, if the price goes above the second support level, the third support stands at $1.5267.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
Market capitalization of the company is 288.47 million based on 162,976K outstanding shares. Right now, sales total 0 K and income totals -111,130 K. The company made 0 K in profit during its latest quarter, and -23,280 K in sales during its previous quarter.
